18F-FDG PET/CT in the Diagnosis of Tuberculous Pericarditis

A total of 11 patients confirmed with tuberculous pericarditis were enrolled in this study to analyze the diagnostic value of 18F-FDG PET/CT for tuberculous pericarditis.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Diagnostic Self Evaluation

Age range

48 year–81 year

Sex eligibility

All sexes

Study type

Observational

About this study

A total of 11 patients with tuberculous pericarditis, who underwent 18F-FDG PET/CT from January 2015 to February 2022 in the affiliated hospital of Jiangnan university were retrospectively reviewed in this study to analyze the diagnostic value of 18F-FDG PET/CT in tuberculous pericarditis.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

patients confirmed as tuberculous pericarditis through follow-up.

Exclusion criteria

patients confirmed as other pericarditis through follow-up.

Treatment and study plan

18F-FDG

Diagnostic Test

18F-FDG intravenous injection

Primary outcomes

the diagnostic sensitivity of 18F-FDG PET/CT for tuberculous pericarditis

Time frame: 01,2015-02,2022

the diagnostic sensitivity of 18F-FDG PET/CT for tuberculous pericarditis

Sponsors and collaborators

Lead sponsor

Wuxi No. 4 People's Hospital

Other

Registry information

Important dates

Study start: 2015
Primary completion: 2022
Study completion: 2022
First posted: Jul 14, 2022
Registry last updated: Jul 14, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed